A study shows that about a quarter of people with clinically diagnosed mild or moderate Alzheimer’s disease (AD) have only minimal β-amyloid (Aβ) deposition on autopsy. And nearly half of patients ...

A large autopsy study revealed advanced CTE was often misdiagnosed as Alzheimer’s, prompting researchers to call for the use of AD blood biomarkers.

PET and MRI scans may together distinguish a new type of dementia from Alzheimer’s disease (AD), a 2026 retrospective, ...

Dementia is a group of disorders that gradually impair memory, thinking and daily functioning. Alzheimer's disease (AD), the most common form of dementia, affects about 7.2 million Americans aged 65 ...

HealthDay News — Lifetime exposure to cognitive enrichment is associated with a lower risk for Alzheimer disease (AD) dementia and a slower rate of cognitive decline, according to a study published ...

A breast cancer battle might come with an unexpected silver lining. New research suggests survivors may have a lower risk of developing Alzheimer’s dementia (AD) compared to women without a history of ...

Many breast cancer survivors experience cognitive impairment, difficulty concentrating, or memory loss during and after treatment. Despite the recognized link between mental cognition and breast ...

A higher cumulative exposure to lead was linked to an increased risk of incident Alzheimer’s disease (AD) and all-cause dementia, according to a February study published in Alzheimer’s & Dementia.

EEG sensors record brain activity (left), generating brainwave signals (middle) that are analyzed by explainable AI (top right) and mapped onto brain regions (bottom right) to detect and interpret ...